These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 31443704)

  • 1. Umbrella and basket trials in oncology: ethical challenges.
    Strzebonska K; Waligora M
    BMC Med Ethics; 2019 Aug; 20(1):58. PubMed ID: 31443704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
    Janiaud P; Serghiou S; Ioannidis JPA
    Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of precision oncology basket and umbrella trials for clinicians.
    Park JJH; Hsu G; Siden EG; Thorlund K; Mills EJ
    CA Cancer J Clin; 2020 Mar; 70(2):125-137. PubMed ID: 32031692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine.
    McGowan ML; Settersten RA; Juengst ET; Fishman JR
    Urol Oncol; 2014 Feb; 32(2):187-92. PubMed ID: 24445286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethical Framework for Including Research Biopsies in Oncology Clinical Trials: American Society of Clinical Oncology Research Statement.
    Levit LA; Peppercorn JM; Tam AL; Marron JM; Mathews DJH; Levit K; Roach N; Ratain MJ
    J Clin Oncol; 2019 Sep; 37(26):2368-2377. PubMed ID: 31343905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Study Designs in Precision Medicine - Basket, Umbrella and Platform Trials.
    Ravi R; Kesari HV
    Curr Rev Clin Exp Pharmacol; 2022; 17(2):114-121. PubMed ID: 34455953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols.
    Park JJH; Siden E; Zoratti MJ; Dron L; Harari O; Singer J; Lester RT; Thorlund K; Mills EJ
    Trials; 2019 Sep; 20(1):572. PubMed ID: 31533793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Cancer Institute Basket/Umbrella Clinical Trials: MATCH, LungMAP, and Beyond.
    Chen AP; Eljanne M; Harris L; Malik S; Seibel NL
    Cancer J; 2019; 25(4):272-281. PubMed ID: 31335391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biostatistical and Logistical Considerations in the Development of Basket and Umbrella Clinical Trials.
    Yee LM; McShane LM; Freidlin B; Mooney MM; Korn EL
    Cancer J; 2019; 25(4):254-263. PubMed ID: 31335389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical considerations of neuro-oncology trial design in the era of precision medicine.
    Gupta S; Smith TR; Broekman ML
    J Neurooncol; 2017 Aug; 134(1):1-7. PubMed ID: 28555425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The New NCI Precision Medicine Trials.
    Harris LN; Blanke CD; Erba HP; Ford JM; Gray RJ; LeBlanc ML; Hu-Lieskovan S; Litzow MR; Luger SM; Meric-Bernstam F; O'Dwyer PJ; Othus MKD; Politi K; Shepherd LE; Allegra CJ; Chen HX; Ivy SP; Korde LA; Little RF; McShane LM; Moscow JA; Patton DR; Thurin M; Yee LM; Doroshow JH
    Clin Cancer Res; 2023 Dec; 29(23):4728-4732. PubMed ID: 37531248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the NCI MATCH trial a match for gynecologic oncology?
    Moore KN; Mannel RS
    Gynecol Oncol; 2016 Jan; 140(1):161-6. PubMed ID: 26586415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges and approaches to implementing master/basket trials in oncology.
    Burd A; Schilsky RL; Byrd JC; Levine RL; Papadimitrakopoulou VA; Herbst RS; Redman MW; Druker BJ; Gandara DR
    Blood Adv; 2019 Jul; 3(14):2237-2243. PubMed ID: 31337605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revolutionizing cancer drug development: Harnessing the potential of basket trials.
    Subbiah V; Burris HA; Kurzrock R
    Cancer; 2024 Jan; 130(2):186-200. PubMed ID: 37934000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology.
    Peppercorn J; Shapira I; Collyar D; Deshields T; Lin N; Krop I; Grunwald H; Friedman P; Partridge AH; Schilsky RL; Bertagnolli MM
    J Clin Oncol; 2010 May; 28(15):2635-40. PubMed ID: 20406927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gatekeeping in cancer clinical trials in Canada: The ethics of recruiting the "ideal" patient.
    Bell JAH; Kelly MT; Gelmon K; Chi K; Ho A; Rodney P; Balneaves LG
    Cancer Med; 2020 Jun; 9(12):4107-4113. PubMed ID: 32314549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.